Nissay Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Nissay Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$29.2M	Buy	65,638 +1,828	+3%	+$814K	0.17%	100
2025 Q1	$30.9M	Buy	63,810 +5,568	+10%	+$2.7M	0.2%	86
2024 Q4	$23.8M	Buy	58,242 +2,879	+5%	+$1.18M	0.15%	100
2024 Q3	$25.7M	Buy	55,363 +3,996	+8%	+$1.86M	0.16%	90
2024 Q2	$24.1M	Buy	51,367 +5,242	+11%	+$2.46M	0.16%	85
2024 Q1	$19.3M	Buy	46,125 +10,167	+28%	+$4.25M	0.13%	106
2023 Q4	$14.6M	Buy	35,958 +3,260	+10%	+$1.33M	0.12%	113
2023 Q3	$11.4M	Buy	32,698 +2,190	+7%	+$762K	0.1%	131
2023 Q2	$10.7M	Sell	30,508 -218	-0.7%	-$76.7K	0.09%	135
2023 Q1	$9.68M	Sell	30,726 -884	-3%	-$279K	0.09%	141
2022 Q4	$9.13M	Sell	31,610 -1,204	-4%	-$348K	0.09%	149
2022 Q3	$9.5M	Buy	32,814 +1,036	+3%	+$300K	0.1%	126
2022 Q2	$8.96M	Buy	31,778 +3,085	+11%	+$869K	0.09%	131
2022 Q1	$7.49M	Buy	28,693 +106	+0.4%	+$27.7K	0.07%	179
2021 Q4	$6.28M	Buy	28,587 +1,026	+4%	+$225K	0.05%	220
2021 Q3	$5M	Buy	27,561 +1,102	+4%	+$200K	0.04%	247
2021 Q2	$5.34M	Buy	26,459 +1,508	+6%	+$304K	0.05%	227
2021 Q1	$5.36M	Sell	24,951 -624	-2%	-$134K	0.05%	207
2020 Q4	$6.04M	Sell	25,575 -1,184	-4%	-$280K	0.09%	183
2020 Q3	$7.28M	Sell	26,759 -4,776	-15%	-$1.3M	0.12%	136
2020 Q2	$9.16M	Buy	31,535 +1,794	+6%	+$521K	0.18%	121
2020 Q1	$7.08M	Buy	29,741 +805	+3%	+$192K	0.18%	127
2019 Q4	$6.34M	Sell	28,936 -1,199	-4%	-$263K	0.14%	167
2019 Q3	$5.11M	Buy	30,135 +1,919	+7%	+$325K	0.12%	189
2019 Q2	$5.17M	Sell	28,216 -1,016	-3%	-$186K	0.13%	176
2019 Q1	$5.38M	Sell	29,232 -1,112	-4%	-$205K	0.14%	168
2018 Q4	$5.03M	Buy	30,344 +798	+3%	+$132K	0.15%	162
2018 Q3	$5.7M	Buy	29,546 +690	+2%	+$133K	0.15%	164
2018 Q2	$4.9M	Sell	28,856 -1,277	-4%	-$217K	0.14%	178
2018 Q1	$4.91M	Sell	30,133 -1,206	-4%	-$197K	0.15%	173
2017 Q4	$4.7M	Buy	+31,339	New	+$4.7M	0.14%	187